Unleash the full power of biology
Our proven genome engineering technologies are powering the next wave of advanced therapeutics, such as iPSC-based and antibody-based therapies
Advance confidently with our bespoke services
Featured products
Accelerate your cell therapy development
ActiCells™ GMP hiPSCs
TARGATT™ Hypo hiPSC Knock-in Kit
- Covered by US FDA Drug Master File (DMF)
- Proven genomic stability (karyotype normal)
- Stable transgene expression post gene editing and
differentiation - No additional pass-through cost
- Hypoimmunogenic through a B2M/CIITA double knock-out
- Ready for additional gene knock-ins for therapeutic and immune evasive payloads
- Express genes from the consistent H11 safe harbor locus
- License-ready with a clear IP path to commercialization
Move faster with ready-to-use products
Unique iPSC cell lines developed
0 +
Successful gene editing projects
0 +
Cell types worked with
0 +
About Applied StemCell
Founded in 2008, Applied StemCell is dedicated to supporting today’s cell therapy discovery, development, and manufacturing efforts and enabling teams to bring the promise of allogeneic therapies to market.
Sign up for our newsletter
Stay up-to-date with the latest news, articles, and offers from Applied StemCell by signing up for our newsletter.